1-4 of 4
Paul Castillo
Close
Sort by
Journal Articles

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

Clinical Trials & Observations
Hemant S. Murthy, Mei-Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly, Ankit Kansagra, Fotios V. Michelis, Taiga Nishihori, Mrinal Patnaik, Muhammad Bilal Abid, Mahmoud Aljurf, Yasuyuki Arai, Ulrike Bacher, Talha Badar, Sherif M. Badawy, Karen Ballen, Minoo Battiwalla, Amer Beitinjaneh, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I. Brown, Rodrigo Martino, Jean-Yves Cahn, Paul Castillo, Jan Cerny, Saurabh Chhabra, Edward Copelan, Andrew Daly, Bhagirathbhai Dholaria, Miguel Angel Diaz Perez, César O. Freytes, Michael R. Grunwald, Shahrukh Hashmi, Gerhard C. Hildebrandt, Omer Jamy, Jacinth Joseph, Christopher G. Kanakry, Nandita Khera, Maxwell M. Krem, Yachiyo Kuwatsuka, Hillard M. Lazarus, Lazaros J. Lekakis, Hongtao Liu, Dipenkumar Modi, Pashna N. Munshi, Alberto Mussetti, Neil Palmisiano, Sagar S. Patel, David A. Rizzieri, Sachiko Seo, Mithun Vinod Shah, Akshay Sharma, Melhm Sohl, Scott R. Solomon, Matthew Ulrickson, Celalettin Ustun, Marjolein van der Poel, Leo F. Verdonck, John L. Wagner, Trent Wang, Baldeep Wirk, Amer Zeidan, Mark Litzow, Partow Kebriaei, Christopher S. Hourigan, Daniel J. Weisdorf, Wael Saber, Mohamed A. Kharfan-Dabaja
Journal: Blood Advances
Blood Adv (2023) 7 (22): 7007–7016.
https://doi.org/10.1182/bloodadvances.2023011308
Published: 2023
Includes: Supplemental data
Journal Articles

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A -rearranged AML

Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait, Jonathan Sanchez, Hai-Lin Wang, Mahmoud Aljurf, Amer Assal, Vera Ulrike Bacher, Sherif M. Badawy, Nelli Bejanyan, Vijaya Raj Bhatt, Christopher Bredeson, Michael Byrne, Paul Castillo, Jan Cerny, Saurabh Chhabra, Stefan Octavian Ciurea, Zachariah DeFilipp, Nosha Farhadfar, Shahinaz Gadalla, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R. Grunwald, Shahrukh Hashmi, Gerhard Hildebrandt, Christopher G. Kanakry, Ankit Kansagra, Farhad Khimani, Maxwell Krem, Hillard Lazarus, Hongtao Liu, Rodrigo Martino, Fotios V. Michelis, Sunita Nathan, Taiga Nishihori, Richard Olsson, Ran Reshef, David Rizzieri, Jacob M. Rowe, Bipin N. Savani, Sachiko Seo, Akshay Sharma, Melhem Solh, Celalettin Ustun, Leo F. Verdonck, Christopher Hourigan, Brenda Sandmaier, Mark Litzow, Partow Kebriaei, Daniel Weisdorf, Yanming Zhang, Martin S. Tallman, Wael Saber
Journal: Blood Advances
Blood Adv (2022) 6 (3): 828–847.
https://doi.org/10.1182/bloodadvances.2021004881
Published: 2022
Includes: Supplemental data
Journal Articles

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients

Clinical Trials & Observations
Leylah M. Drusbosky, Neeraj Kumar Singh, Kimberly E. Hawkins, Cesia Salan, Madeleine Turcotte, Elizabeth A. Wise, Amy Meacham, Vindhya Vijay, Glenda G. Anderson, Charlie C. Kim, Saumya Radhakrishnan, Yashaswini Ullal, Anay Talawdekar, Huzaifa Sikora, Prashant Nair, Arati Khanna-Gupta, Taher Abbasi, Shireen Vali, Subharup Guha, Nosha Farhadfar, Hemant S. Murthy, Biljana N. Horn, Helen L. Leather, Paul Castillo, Caitlin Tucker, Christina Cline, Leslie Pettiford, Jatinder K. Lamba, Jan S. Moreb, Randy A. Brown, Maxim Norkin, John W. Hiemenz, Jack W. Hsu, William B. Slayton, John R. Wingard, Christopher R. Cogle
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1837–1847.
https://doi.org/10.1182/bloodadvances.2018028316
Published: 2019
Includes: Supplemental data
Journal Articles

Sequential allogeneic and autologous CAR-T–cell therapy to treat an immune-compromised leukemic patient

Clinical Trials & Observations
Jian-Ping Zhang, Rui Zhang, Shih-Ting Tsao, Yu-Chen Liu, Xiaochuan Chen, Dao-Pei Lu, Paul Castillo, Lung-Ji Chang
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1691–1695.
https://doi.org/10.1182/bloodadvances.2018017004
Published: 2018